Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-κb ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism
- 1 July 2004
- Vol. 35 (1) , 256-265
- https://doi.org/10.1016/j.bone.2004.03.012
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Osteoprotegerin Levels in Primary Hyperparathyroidism: Effect of Parathyroidectomy and Association with Bone MetabolismCalcified Tissue International, 2003
- Importance of Membrane- or Matrix-Associated Forms of M-CSF and RANKL/ODF in Osteoclastogenesis Supported by SaOS-4/3 Cells Expressing Recombinant PTH/PTHrP ReceptorsJournal of Bone and Mineral Research, 2000
- Osteoprotegerin Ligand Regulates Osteoclast Adherence to the Bone Surface in Mouse CalvariaBiochemical and Biophysical Research Communications, 2000
- In Vivo Demonstration that Human Parathyroid Hormone 1–38 Inhibits the Expression of Osteoprotegerin in Bone with the Kinetics of an Immediate Early GeneJournal of Bone and Mineral Research, 2000
- Expression of functional RANK on mature rat and human osteoclastsFEBS Letters, 1999
- Site of Osteodensitometry in Perimenopausal Women: Correlation and Limits of Agreement Between Anatomic RegionsJournal of Bone and Mineral Research, 1997
- Use of the Polymerase Chain Reaction in Quantification of Interleukin 8 mRNA in Minute Epidermal SamplesJournal of Investigative Dermatology, 1992
- Parathyroid hormone promotes the disassembly of cytoskeletal actin and myosin in cultured osteoblastic cells: Mediation by cyclic AMPJournal of Cellular Biochemistry, 1991
- Changes in cytoskeletal proteins in response to parathyroid hormone and 1,25-dihydroxyvitamin D in human osteoblastic cellsBone and Mineral, 1990
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987